Eli Lilly to invest over $1 billion in India to scale up manufacturing, boost global supply chain resilience
Global pharmaceutical giant Eli Lilly has announced plans to invest more than $1 billion in India over the next few years to expand its manufacturing capacity, signaling a major vote of confidence in the country’s pharma ecosystem. The investment, which will be deployed across greenfield facilities, technology upgrades, and workforce expansion, is aimed at strengthening…